• Journal of Preventive Medicine and Public Health
• /
• 제56권6호
• /
• pp.523-532
• /
• 2023

Objectives: During the second coronavirus disease 2019 (COVID-19) surge, cases increased sharply due to low awareness and compliance with measures to limit disease spread. Health literacy (HL) is an important component of public health initiatives, and schools are potential sources of health education to increase HL via the presentation of COVID-19 educational modules. Methods: This cross-sectional study involved an online questionnaire administered to students from 5 high schools in Surabaya and Sidoarjo, Indonesia, 6-7 weeks after the start of government-issued directives restricting public gatherings. We collected data on each respondent's age, gender, parental education, and socioeconomic variables. HL was determined by the Health Literacy Measure for Adolescents. We additionally measured their attitudes and behaviors related to preventing the spread of COVID-19. The students were asked if they watched the COVID-19 module at school, their feelings about vaccination, and preferred online sources of COVID-19-related information. Results: Most of the 432 respondents had viewed COVID-19 modules at school. Module exposure was associated with significantly higher total and domain-specific HL and more positive attitudes toward government-issued COVID-19 restrictions on travel and public gatherings (p<0.05). However, behaviors to prevent COVID-19 spread and vaccine acceptance were not associated with module exposure. Most students chose social media as their source of COVID-19-related information. Conclusions: Schools can provide information to increase adolescents' HL and the public's support for health initiatives to prevent or limit the spread of COVID-19.

• 한국언론정보학보
• /
• 제34권
• /
• pp.63-97
• /
• 2006

본 연구는 한국의 기업 PR 수단 및 활동의 발전과정에 미친 외적요인을 일본의 영향을 중심으로 고찰하였다. 이를 위해 본 연구는 기업 PR 커뮤니케이션 수단의 경우 CIP 도입과 수용, 기업 PR광고, 사보를 중심으로, 기업 PR활동의 경우 기업재단을 통한 사회공헌활동과 경제계 PR 활동을 중심으로 살펴보았다. 기업 PR과 관련하여 기업 PR 활동의 특성을 중심으로 한국 기업의 PR 활동의 강조점과 커뮤니케이션 수단 활용 측면의 고찰을 통해 일본의 영향을 분석하였다. PR 발달사적 측면에서 기업 PR관련 영역들을 중심으로 한국의 상황과 일본의 상황 비교를 통해 분석대상으로 선정한 문제들에 접근하였다. 분석결과 한국에서의 기업 PR 수단 및 활동영역의 발전과정에 일본이 많은 영향을 미쳤음을 알 수 있었다. 그러나 일본 기업 PR의 시작과 발전은 PR 이론과 PR 실무 및 관행 측면에서 많은 부분 PR의 발상지며 종주국인 미국의 것을 받아들였음은 이론의 여지가 있다. 따라서 미국으로부터의 직접적 경로가 아닌 일본을 통한 간접적 도입의 형태로 일본에서 도입 발전된 방식으로 한국에서 수용 발전되었다 하더라도 미국의 영향이 존재함은 부정할 수 없을 것이다.

• 한국응용약물학회:학술대회논문집
• /
• 한국응용약물학회 2006년도 Proceedings of The Convention
• /
• pp.23-39
• /
• 2006

The application of the knowledge from the Human Genome Project to clinical medicine will be through both industrial drug development and the application of pharmacogenomics (PG) to patient care. The slow uptake of clinical innovations into clinical practice can be frustrating, but understanding the history of acceptance and sustaining medical innovation is critically important to position PG to succeed. This primarily means that PG tests must have legitimacy; they must be thoroughly validated, must be cost-effective, must be widely accepted by medical practitioners, must be supported by public policy, and must have a way of being easily incorporated into current medical practice. They must also lead to actionalble decisions by health care providers for their patients. Innovative PG assays should be tested in the best US laboratories, and reimbursement for testing must be accepted at the federal and state level. The companies providing these PG tests should be capable of supporting the interpretation and use of the test throughout medical practice. Advances such as the addition of PG information to drug labeling and the routine use of validated biomarkers to determine choice of cancer chemotherapy have been made. The PG research community must pay attention to the principles that have been previously described for acceptance and sustaining medical innovations in order for PG to be widely accepted in clinical medical practice.

• 산업경영시스템학회지
• /
• 제33권4호
• /
• pp.130-137
• /
• 2010

This paper analyzes the main factors affecting user selection of a small-sum electronic payment system using survey data of 396 users. Several findings emerge. First, users consider three pillars and eight factors in adopting a new system : system features(stability, security, and flexibility), transaction cost(payment commission and settlement period), and financial capability of provider(stability of financial structure, risk management capability, and funding capability). Second, the stability of the financial structure of the system provider is the most important factor to user acceptance of a new e-payment system. Users tend to consider uncertainty risk more seriously than transaction cost. This reflects the reality that electronic payment system service industry has not fully fledged yet. Third, some moderating effects exist according to payment methods and business usages. As for payment methods, speedy settlement cycle for wired/wireless phone payment, system stability for credit card and account transfer payment, and security for advance payment means are crucial factors. As for business usages, the stability of financial structure for online game content, system stability for music and video content, proxy payment commission for e-learning content, flexibility of the payment system for digital adult content, and security for public services are decisive ones.

• 복식
• /
• 제62권2호
• /
• pp.13-25
• /
• 2012

The purpose of this research is to study the influence over confidence and Word-Of-Mouth (WOM) effect in the acceptance process of WOM by information characteristics(consensus, vividness, and message neutrality) of individual cosmetic blog, reflecting that it is widely spreading over the public. Online survey for the consumers using such blogs was performed to collect data(N=200), and credibility analysis through Cronbach-${\alpha}$ and Structural Equation Model(SEM) analysis using AMOS 18.0 were performed. The analysis results are as follows; First, vivid information and neutral message increase WOM effect through the improvement of consumers' credibility whereas information consensus doesn't positively influence over credibility. Second, the examination of a moderating effect by type of cosmetics demonstrated that the consumers of basic cosmetics have most confidence in vivid information, and those of color cosmetics do more confidence in neutral message. Therefore, there is a difference in the credibility factor of online WOM depending on the type of cosmetics consumption so that differentiated information provision strategies for cosmetics groups should be established based on it.

• Biomolecules & Therapeutics
• /
• 제15권1호
• /
• pp.1-6
• /
• 2007

The application of the knowledge from the Human Genome Project to clinical medicine will be through both industrial drug development and the application of pharmacogenomics (PG) to patient care. The slow uptake of clinical innovations into clinical practice can be frustrating, but understanding the history of acceptance and sustaining medical innovation is critically important to position PG to succeed. This primarily means that PG tests must have legitimacy; they must be thoroughly validated, must be cost-effective, must be widely accepted by medical practitioners, must be supported by public policy, and must have a way of being easily incorporated into current medical practice. They must also lead to actionalble decisions by health care providers for their patients. Innovative PG assays should be tested in the best US laboratories, and reimbursement for testing must be accepted at the federal and state level. The companies providing these PG tests should be capable of sup-porting the interpretation and use of the test throughout medical practice. Advances such as the addition of PG information to drug labeling and the routine use of validated biomarkers to determine choice of cancer chemotherapy have been made. The PG research community must pay attention to the principles that have been previously described for acceptance and sustaining medical innovations in order for PG to be widely accepted in clinical medical practice.

• Preventive Nutrition and Food Science
• /
• 제7권2호
• /
• pp.207-214
• /
• 2002

Food preference of children may be determined by various lifestyle and environmental factors. This study evaluated the effect of rural or urban inhabitance, cooking methods, and frequency of exposure to vegetable dishes on the acceptance of vegetables by 452 fifth grade children. The subjects were students utilizing meal service in public elementary schools in Boryeoung-city, Chungcheong-nam-do (urban); Cheolwon-gun, Gangwondo (rural); or Pocheon-gun, Kyeonggi-do (suburban). A survey was used to determine the preference of students for 59 foods containing vegetables as a primary ingredient, and categorized by fat content (high, low, or intermediate). Children with working mothers and those living in urban areas tended to have less preference for vegetables than their counterparts in rural areas or with mothers who remained at home. Preference for vegetable foods was correlated with the frequency that vegetable foods were prepared by mothers. Vegetable dishes with a high fat content were preferred over those with low or intermediate fat content, except far soup. This study suggests that children who live in urban areas and whose mothers work outside of the home may be predisposed to nutritional deficiencies due to poor acceptance of vegetable foods, and that all children may be at risk for over-consumption of dietary fat, due to a preference for high fat foods.

• 자동차안전학회지
• /
• 제7권3호
• /
• pp.30-34
• /
• 2015

This study examined the Korean drivers' acceptance of SAS(Speed Assistance systems) and traffic sign conditions in Korea roads for SLIF(Speed Limit Information Function) that is a part of SAS. Exceeding the speed limit is a factor in the severity of many road accidents and SAS would help the driver to observe a speed limit by warning and/or effectively limiting the speed of the vehicle. SAS are in the initial phase in Korea, Korean drivers could not be familiar with automatical speed limiting during driving, SAS interface design would be considered to be more readily acceptable to the public. And advanced SAS have been introduced onto the market which are able to inform the driver of the current speed limit based on camera and/or digital maps based SLIF. These systems are based on external data using sensors, so environmental conditions are an important factor which could cause malfunction of SLIF functions.

• Journal of Plant Biotechnology
• /
• 제45권4호
• /
• pp.299-305
• /
• 2018

Although new plant breeding technologies facilitate efficient plant breeding without introducing a transgene, they are creating indistinct boundaries in the regulation of genetically modified organisms (GMOs). The rapid advancement in plant breeding by genome-editing requires the establishment of a new global policy for the new biotechnology, while filling the gap between process-based and product-based GMO in terms of regulations. In this study recent developments in producing major crops using new plant breeding technologies were reviewed, and a regulatory model that takes into account the various methodologies to achieve genetic modifications as well as the resulting types of mutation were proposed. Moreover, the communication process were discussed in order to understand consumers' current situation and problems of new plant breeding technology, establish social acceptance well, and understand consumers' disputes such as GMO crops.

• 한국약용작물학회:학술대회논문집
• /
• 한국약용작물학회 2006년도 Proceedings of The Convention of The Korean Society of Applied Pharmacology
• /
• pp.23-39
• /
• 2006

The application of the knowledge from the Human Genome Project to clinical medicine will be through both industrial drug development and the application of pharmacogenomics (PG) to patient care. The slow uptake of clinical innovations into clinical practice can be frustrating, but understanding the history of acceptance and sustaining medical innovation is critically important to position PG to succeed. This primarily means that PG tests must have legitimacy; they must be thoroughly validated, must be cost-effective, must be widely accepted by medical practitioners, must be supported by public policy, and must have a way of being easily incorporated into current medical practice. They must also lead to actionalble decisions by health care providers for their patients. Innovative PG assays should be tested in the best US laboratories, and reimbursement for testing must be accepted at the federal and state level. The companies providing these PG tests should be capable of supporting the interpretation and use of the test throughout medical practice. Advances such as the addition of PG information to drug labeling and the routine use of validated biomarkers to determine choice of cancer chemotherapy have been made. The PG research community must pay attention to the principles that have been previously described for acceptance and sustaining medical innovations in order for PG to be widely accepted in clinical medical practice.